A report from the American Cancer Society Cancer Action Network and Georgetown University Center on Health Insurance Reforms shows that while opportunities for coverage have improved, cancer patients struggle with financial challenges in affording their treatment, despite reductions in out-of-pocket costs and patient protections under current law.
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.
